Launch of LiMoN-2

LiMoN-2, the transcontinental project between the Cognitive Neuroscience Center (Argentina), the Catholic University of San Pablo (Peru), and the University of Geneva (Switzerland), was launched in Peru. The project integrates TELL and EEG to detect linguistic markers of neurodegeneration in bilinguals. Congratulations to the whole team!

Word by word: Enhancing cognitive testing in Parkinson’s disease

Words are more than vehicles of thought—they are markers of brain health. In this perspective, Atlantic Fellow Adolfo García and biomedical engineer Franco Ferrante dissect their research on how verbal fluency tests reveal cognitive changes in Parkinson’s disease. To read the full article, click here.

Of words, algorithms, and brain disorders (in Spanish)

Given the lack of diagnostic resources, speech analysis using artificial intelligence algorithms is emerging as an accessible, accurate, and promising tool for identifying pathologies in their early stages. You can read the full article, in Spanish, here.     Frente a la falta de recursos diagnósticos, el análisis del habla mediante algoritmos de inteligencia artificial […]

Visit to NIMHANS in Bangalore, India

Dr. Adolfo García visited NIMHANS in Bangalore during the TELL 2025 India tour in November. We are excited to create new connections around language and brain health.

Visit to Mahindra University in Hyderabad, India

Dr. Adolfo García visited Mahindra University in Hyderabad during the TELL 2025 India tour in November. We are excited to extend our collaboration with Davos Alzheimer’s as we keep leveraging speech biomarkers for lifelong brain health solutions.

Keynote talk for the University of São Paulo

Dr. Adolfo García gave a keynote lecture at the Hospital de Clínicas of the University of São Paulo School of Medicine, where he spoke about speech biomarkers in neurodegeneration.